Cargando…

Discontinuation Patterns and Cost Avoidance of a Pharmacist-Driven Methicillin-Resistant Staphylococcus aureus Nasal Polymerase Chain Reaction Testing Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia

A pharmacist-driven methicillin-resistant Staphylococcus aureus (MRSA) nasal polymerase chain reaction (PCR)-based testing protocol with a 70% acceptance rate for vancomycin discontinuation within 24 hours of negative results significantly reduced unnecessary vancomycin use with an estimated cost av...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, L, Pourali, S, Hitchcock, M M, Ha, D R, Mui, E, Alegria, W, Fox, E, Diep, C, Swayngim, R, Chang, A, Banaei, N, Deresinski, S, Holubar, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355456/ https://www.ncbi.nlm.nih.gov/pubmed/34386545 http://dx.doi.org/10.1093/ofid/ofab099

Ejemplares similares

1489. Safety and Performance of a Pharmacist-Driven Nasal MRSA PCR Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia at an Academic Medical Center
por: Meng, Lina, et al.
Publicado: (2020)

Effect of rapid methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction screening on vancomycin use in the intensive care unit
por: Diep, Calvin, et al.
Publicado: (2021)

Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia
por: Fox, Emily, et al.
Publicado: (2022)

Use of nares swab to de-escalate vancomycin for patients with suspected methicillin-resistant Staphylococcus aureus
por: Gentges, Joshua, et al.
Publicado: (2023)

1224. Outcomes of Empirical Vancomycin De-escalation Based on Methicillin-Resistant Staphylococcus aureus Nares
por: Xu, Jiachen, et al.
Publicado: (2023)

182. Missed Opportunities to Discontinue Unnecessary Vancomycin During Pharmacist Therapeutic Monitoring
por: Medler, Corey J, et al.
Publicado: (2020)

1073. Predictors of Vancomycin Switch or Escalation in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection
por: Lagnf, Abdalhamid M, et al.
Publicado: (2018)

Impact of a Pharmacist-driven Methicillin-resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Swab Protocol on the De-escalation of Empiric Vancomycin in Patients with Pneumonia in a Rural Healthcare Setting
por: Dadzie, Precious, et al.
Publicado: (2019)

PCR Cycle-Threshold-Derived Toxin Identifies Patients at Low-Risk for Complications of C. difficile Infection Who Do Not Require Treatment
por: Hitchcock, Matthew, et al.
Publicado: (2017)

1092. Tuning Down Clostridioides difficile PCR Sensitivity Reduces Treatment for C. difficile Infection in Toxin-Negative Patients With No Increase in Adverse Outcomes
por: Hitchcock, Matthew, et al.
Publicado: (2018)

Pharmacist-Driven MRSA Nasal PCR Screening and the Duration of Empirical Vancomycin Therapy for Suspected MRSA Respiratory Tract Infections
por: Woolever, Nathan L., et al.
Publicado: (2020)

227. Evaluation of Empiric Vancomycin Utilization at 72 Hours Post Admission: is De-escalation of Vancomycin Appropriate?
por: Naderi, Mandana, et al.
Publicado: (2020)

824. Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience
por: Lu, Brian, et al.
Publicado: (2023)

Elimination of Aerosol Ribavirin Use in Immunocompromised Patients with Metapneumovirus and Parainfluenza Virus Infections
por: Mui, Emily, et al.
Publicado: (2017)

2003. Vancomycin Discontinuation Is Supported by-negative Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) in Patients with Pneumonia
por: Pleasants, Katherine A, et al.
Publicado: (2019)

Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus
por: Komoto, Atsushi, et al.
Publicado: (2018)

2807. Using Less of Our Big Guns: Vancomycin De-Escalation Using Methicillin-Resistant Staphylococcus aureus Nasal Swab Screening Protocol
por: Sittirat, Petchpailin D, et al.
Publicado: (2023)

210. Step-down from IV to oral therapy in patients with bacteremia due to Enterobacteriaceae: fluoroquinolones (FQ) vs. ß-lactams (BL) or trimethoprim-sulfamethoxazole (TMP-SMX)
por: Meng, Lina, et al.
Publicado: (2019)

79. Outcomes Associated with the Utilization of the Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Polymerase Chain Reaction (PCR) Assay to De-escalate Vancomycin Therapy in Patients with Suspected Pneumonia at a Rural Community Hospital
por: Tirupathi, Raghavendra, et al.
Publicado: (2020)

Early Switch and Early Discharge Opportunities in Intravenous Vancomycin Treatment of Suspected Methicillin-Resistant Staphylococcal Species Infections
por: Parodi, Stephen, et al.
Publicado: (2003)

Piperacillin/tazobactam versus cefepime or carbapenems for cefoxitin-non-susceptible Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii, Serratia marcescens and Morganella morganii bacteraemia in immunocompromised patients
por: Lu, Brian, et al.
Publicado: (2023)

197. Implementation of a Prospective, Pharmacist-Led Methicillin-Resistant Staphylococcus aureus Nasal PCR Screening Pilot Protocol to Reduce Overutilization of Vancomycin
por: Miller, Jessica, et al.
Publicado: (2018)

Comparison of Empiric Antibiotic Escalation Therapy with Vancomycin (VAN) versus Linezolid (LIN) in Patients with Febrile Neutropenia
por: Mayer, Karin, et al.
Publicado: (2022)

Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
por: Panesso, Diana, et al.
Publicado: (2015)

2532. Identifying Educational Needs and Improving Provider Knowledge Regarding the Management of Febrile Neutropenia
por: Chang, Amy, et al.
Publicado: (2019)

Methicillin and Vancomycin Resistant S. aureus in Hospitalized Patients
por: Loomba, Poonam Sood, et al.
Publicado: (2010)

“Acute urinary antibiotics”—A simple metric to identify outpatient antibiotic stewardship opportunities in renal transplant
por: Zimmet, Alex, et al.
Publicado: (2023)

1266. Refining Antimicrobial Stewardship by De-escalating Vancomycin Using MRSA (Methicillin Resistant Staphylococcus aureus) Nasal Screening in a Community Hospital Setting
por: Shah, Ruta, et al.
Publicado: (2023)

Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention
por: Benamu, Esther, et al.
Publicado: (2018)

The Impact of Concomitant Empiric Cefepime on Patient Outcomes of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections Treated With Vancomycin
por: Zasowski, Evan J, et al.
Publicado: (2019)

Pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes
por: Gregory, Eric R., et al.
Publicado: (2022)

Vancomycin MIC Distribution among Methicillin-Resistant Staphylococcus Aureus. Is Reduced Vancomycin Susceptibility Related To MIC Creep?
por: Othman, Hala B., et al.
Publicado: (2018)

901. Evaluation of Azithromycin Usage Following a Pharmacist Discontinuation Protocol
por: Percival, Kelly M, et al.
Publicado: (2022)

1999. Does Pharmacist-Driven Methicillin-Resistant Staphylococcus aureus PCR Nasal Screening Decrease Time to De-Escalation of MRSA Coverage in Patients with Pneumonia?
por: Waters, Dustin, et al.
Publicado: (2019)

Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan
por: Wang, Jiun-Ling, et al.
Publicado: (2004)

Corrigendum to: The Impact of Concomitant Empiric Cefepime on Patient Outcomes of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections Treated With Vancomycin
por: Zasowski, Evan J, et al.
Publicado: (2020)

Vancomycin Tolerant, Methicillin-Resistant Staphylococcus aureus Reveals the Effects of Vancomycin on Cell Wall Thickening
por: Cázares-Domínguez, Vicenta, et al.
Publicado: (2015)

Sustained Reduction in Urgent Care Antibiotic Prescribing During the Coronavirus Disease 2019 Pandemic: An Academic Medical Center’s Experience
por: Ha, David, et al.
Publicado: (2022)

Clinical Outcomes With Definitive Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia With Retained Daptomycin and Ceftaroline Combination Therapy vs De-escalation to Monotherapy With Vancomycin, Daptomycin, or Ceftaroline
por: Nichols, Courtney N, et al.
Publicado: (2021)

Oral Fluoroquinolone or Trimethoprim-Sulfamethoxazole vs ß-Lactams as Step-Down Therapy for Enterobacteriaceae Bacteremia: Systematic Review and Meta-analysis
por: Punjabi, Chitra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6obof2orbhmeg54o0h38ql79b2